Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

IFN-γ Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host

Xiao Song Liu, Joanne Leerberg, Kelli MacDonald, Graham R. Leggatt and Ian H. Frazer
J Immunol July 1, 2009, 183 (1) 51-58; DOI: https://doi.org/10.4049/jimmunol.0802047
Xiao Song Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanne Leerberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelli MacDonald
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham R. Leggatt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian H. Frazer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Ags characterizing tumors or chronic viral infection are generally presented to the host immune system before specific immunotherapy is initiated, and consequent generation of regulatory CD4+ T cells can inhibit induction of desired effector CD8 T cell responses. IL-10 produced in response to ongoing Ag exposure inhibits generation of CD8 T cells in an Ag-experienced host. We now show that this IL-10 is produced by Ag experienced CD4+ glucocorticoid-induced tumor necrosis factor receptor+ T cells that also secrete IFN-γ upon antigenic stimulation, that IL-10 secretion by these cells is enhanced through IFN-γ signaling, and, unexpectedly, that IFN-γ signaling is required for inhibition of generation of Ag-specific CD8 T cell responses in an Ag-experienced host. Systemic inhibition of both IL-10 and IFN-γ at the time of immunization may therefore facilitate induction of effective immunotherapeutic responses against tumor specific and viral Ags.

Induction by immunization of Ag-specific cellular effector mechanisms designed to treat cancer and chronic viral infection is still experimental (1), in contrast to induction of Ab to prevent infection which is widely practiced. One of the striking differences between effective prophylactic and noneffective therapeutic vaccines is that tumor or viral infected individuals usually develop ineffective immune responses to tumor or viral Ag before immunotherapy is attempted.

Persistent infection with human papillomavirus (HPV)3 is causal for cervical cancer, the second most common cancer in women worldwide (2). Persistent HPV infection develops in 2% of patients, and is associated with humoral or cellular immune responses to papillomavirus structural and nonstructural proteins unable to induce regression of infection (3). The major papillomavirus structural protein (L1) can self assemble into virus-like particles in vitro, and these are the basis of vaccines that prevent HPV infection (4). Papillomavirus virus-like particles incorporating foreign protein can deliver foreign Ag and induce effective cytotoxic T cells that cause regression of transplantable tumors in preclinical studies (5, 6, 7). However, the same particles have proven ineffective at inducing therapeutic immunity when used to immunize patients with persisting HPV infection (8), suggesting that prior exposure to Ag can alter the hosts’ ability to respond to these particles. We have established a mechanism for this observation in an animal model using papillomavirus capsid protein virus-like particles expressing an additional papillomavirus Ag, E7 (9, 10). Immunization with L1-E7 virus-like particles induced E7 specific IFN-γ secreting CD8 T cells in naive animals but not in animals already primed to L1. Inhibition required Ag-experienced CD4 T cells and IL-10, and did not require natural regulatory CD4+CD25+ T cells. Similarly, neutralizing IL-10 at the time of DNA vaccination has recently been demonstrated to generate CD8 T cells and clear chronic viral infection in a mouse lymphocytic choriomeningitis virus model (11, 12, 13).

Regulatory T cells control immune responses to self Ag, transplantation, infection, and tumor responses. Naturally occurring thymus-derived CD4+CD25+ regulatory T cells expressing Foxp3 and acting through cell-cell contact do not appear to be primed to specific Ags (14), in contrast to regulatory T cells (Tr1) generated after antigenic stimulation and acting though IL-10 secretion (15, 16). Tumor specific T regulatory cell lines can be established from patients (17), including those with cervical cancer (18). A study using TCR transgenic T cells specific for influenza virus hemagglutinin Ag, and a tumor cell line expressing hemagglutinin Ag (19), demonstrated that immunotherapy amplifies tumor specific T regulatory cells and thus hampers the effectiveness of immunotherapy, which may explain the ineffectiveness of immunotherapy in Ag experienced hosts. In the current study, we demonstrate that IL-10 secretion by Ag-experienced CD4+CD25+glucocorticoid-induced tumor necrosis factor receptor (GITR)+ T cells in response to their cognate Ag is enhanced by IFN-γ and, surprisingly, that IFN-γ signaling to these regulatory T cells is required for IL-10 mediated suppression of CD8 specific responses in an Ag-primed host.

Materials and Methods

Mice

Four- to eight-week-old adult female C57BL/6 (H-2b) mice were purchased specific pathogen free from the Animal Resource Centre (Perth, Australia). CD1d knockout (CD1d−/−) mice, and IFN-γ receptor knockout mice (IFN-γR−/− mice), each on at C57BL/6 background, were sourced from The Jackson Laboratory and bred in the biological resources facility at Princess Alexandra Hospital. Mice were kept under specific pathogen free conditions throughout, and all experiments were approved by and performed in compliance with the guidelines of the University of Queensland Animal Experimentation Ethics Committee.

Cell lines, peptides, and Abs

Spodoptera frugiperda (Sf-9) cells (Life Technique) were maintained in Sf-900 II medium with Sf-9 II Supplement (Life Technique) and 10% FBS (CSL) at 27°C. Anti-IL-10 receptor (anti-IL-10R) hybridoma (1B1.3a) (10) was provided by Dr. Warwick Britton of Centenary Institute, University of Sydney and was maintained in RPMI 1640 (Invitrogen) with 10% FBS.

Production of anti-IL-10 mAb has been described elsewhere (10). In brief, hybridoma cells were cultured in RPMI 1640 with 1% FBS for 72 h; supernatants were collected and passed through a Protein G column (Sigma-Aldrich) and eluted by running 100 mM glycine (Sigma-Aldrich) through the column. Eluted Abs were dialyzed extensively against PBS (0.15 M NaCl; 0.02 M PO4 (pH 7.4)) and the concentration of Ab was measured and bioactivity was assessed by an in vitro suppression assay as previously described (9).

Anti-CD4 mAb (GK1.5) and anti-CD8 mAb (2.43) were produced from mouse ascites. Anti CD4-FITC mAb (RM4-4), anti-IL-10 mAb (JES5-16E3), anti-CD4-PE (RM 4-5), anti-GITR-PE (RAM34), anti-CCR5 (7A4), anti-CCR7 (4B12), were purchased from eBioscience. Anti-IFN-γ (R4-6A2), anti-IFN-γ α-chain (GR20) was purchased from BD Pharmingen. Anti-IFN-γ β-chain (MOB-47) and anti-CD3 (145-2C11) was purchased from Bio-Legend.

IFN-γ was purchased from eBioscience. OVA, zymosan, and LPS were purchased from Sigma-Aldrich.

The MHC class I (H-2 Db) restricted HPV16 E7 peptide RAHYNIVTF (20) was synthesized and purified by Chiron Mimotopes.

Production of recombinant virus-like particles (VLPs)

VLP of various papillomaviruses were produced using recombinant baculoviruses encoding the L1 protein of bovine papillomavirus (L1 VLPs) or a synthetic fusion protein comprising the L1 protein of bovine papillomavirus and a cytotoxic T cell epitope of HPV16 E7 protein (RAHYNIVTF; single letter amino acid code) (L1E7 VLPs) as previously described (21). VLPs were purified from the nuclei of SF9 cells infected with recombinant baculovirus by CsCl gradient centrifugation as previously described (22). Samples were subjected to analysis by transmission electron microscope and immunoblotting to confirm the identity and integrity of the VLPs. For immunoblot analysis, protein samples were diluted in SDS-PAGE sample buffer, electrophoresed through a 10% SDS-PAGE gel, and transferred to nitrocellulose membrane. The membrane was probed with the anti-L1 mAb MC15. Bound Ab was detected by incubation of the membrane with HRP-conjugated sheep anti-mouse Ab (Silenus) and visualized using ECL (Amersham Biosciences). For electron microscopy, CsCl gradient-purified and dialysed VLP samples were mounted onto carbon-coated grids, stained with 2% ammonium molybdate (pH 6.2), and examined with a Hitachi H-800 electron microscope.

Immunization of mice

Groups of three to five mice were immunized as indicated with 30 or 50 μg of VLPs i.m. without any adjuvant; or were immunized with 100 μg of OVA and 30 μg of LPS i.p. Mice were lightly anesthetized with Isofluorane (Abbott).

ELISA for IL-10 and IFN-γ cytokines from culture supernatants

ELISA for IL-10 and IFN-γ (R&D Systems) was performed as described previously, according to the manufacturer’s recommended procedures (9).

ELISPOT

ELISPOT was performed as described (23). In brief, single spleen cell or lymph node suspensions were added to membrane base 96-well plates (Millipore) coated with anti-IFN-γ (BD Harlingen). Peptide was added at various concentrations and cells held at 37°C with peptide for 18 h. Ag specific IFN-γ secreting cells were detected by sequential exposure of the plate to biotinylated anti-IFN-γ (BD Harlingen), avidin-HRP (Sigma-Aldrich) and diaminobenzidine (Sigma-Aldrich). The IFN-γ secreting cells were quantitated by ELISPOT reader system ELR02 (AID Autoimmun Diagnostica).

Positive selection of mouse spleen CD11c+ cells

Positive selection of mouse spleen CD11c+ cells has been described previously (10). In brief, C57 BL/6 or IFN-γR−/− mouse spleens were held in 1 mg/ml Collagenase D (Roche Diagnostics) and 500 μl of Collagenase D was injected into each spleen. The spleens were then cut in smaller pieces, held in 5 ml of Collagenase D for 45–60 min at 37°C, and passed through a steel mesh. The cells were counted, washed in RPMI 1640 with 2% FBS, and resuspended in 400 μl RPMI 1640 with 2% FBS per 108 total cells. One hundred microliters of MACS CD11c Microbeads (Miltenyi Biotec) were added, and held for 15 min at 6–12°C. After washing, cells were resuspended in 500 μl per 108 cells. CD11c+ cells were positively selected with a LS column (Miltenyi Biotec) according to the manufacturer’s protocols. The purity of CD11c+ cells was around 80% as assessed by flow cytometry.

Sorting of CD4+ T cells

To generate a lymphocyte population enriched for Ag primed CD4+ T cells, mice were immunized with L1VLPs twice, and draining inguinal lymph nodes were removed 7 days after the second immunization. Cells were passed through a 70-μm nylon membrane (BD Harlingen) and resuspended in 1 ml RPMI 1640 plus 2% FBS. The cells were stained for CD4 and GITR expression. CD4+GITR+, or CD4+GITR− cells from draining, nondraining lymph nodes of C57 BL/6 or IFN-γR−/− mouse were sorted by using high-speed sorter MoFlo Flow (DakoCytomation). Sorted cells had >95% purity and the CD11c+ cells within the sorted cells were <2%.

In some experiments, CD4+ T cells were negatively enriched and then CD4+GITR+ T cells were positively selected by using MACS beads following the protocols from manufacturer. The purity of CD4+GITR+ T cells was around 90%.

Intracellular staining for Foxp3 and cytokines

Intracellular staining of lymphocytes from spleen and lymph nodes Foxp3 was performed using an Foxp3 intracellular staining kit from eBioscience following the instructions provided.

For the intracellular staining of cytokines, single cell suspensions were made from spleen or lymph nodes from immunized mice and stimulated with 25 ng/ml PMA and 1 μg/ml ionomycin for 3–5 h in the presence of monensin (BioLegend). For some experiments, the cells were cultured for 72 h in the presence of anti-CD3 and equal number of CD11c+ cells and then stimulated with same concentration of PMA and ionomycin for 5 h. After stimulation, intracellular staining for IL-10 and IFN-γ was performed using Per/Fix reagents (BD Pharmingen).

Statistical analysis

Statistical analysis was performed using the two tailed Student’s test, using Prism 4.0 (GraphPad Software).

Results

Ag-experienced CD4+GITR+ T cells secrete IL-10 upon antigenic stimulation

Animals primed to Ag by immunization are inhibited from producing IFN-γ-secreting CD8 T cells in response to further immunization with Ag, and inhibition requires primed CD4 T cells and IL-10. To identify which population of Ag experienced CD4+ T cells produce IL-10 and suppress induction of effector cells in Ag primed mice, we immunized mice with bovine papillomavirus 1 L1 virus like particles (L1 VLPs) and compared CD4+ T cells from lymph nodes draining the site of immunization with cells from non draining lymph nodes for GITR and Foxp3 expression. The percentage of CD4 cells expressing GITR was similar between draining and nondraining lymph nodes, while Foxp3 expression was slightly lower in draining lymph nodes (Fig. 1⇓A). However, while equal numbers of CD4+GITR+ T cells expressed or did not express FoxP3 in the draining lymph nodes, in non draining lymph nodes the majority of CD4+GITR+ T cells were also FoxP3 positive (Fig. 1⇓B). These results suggested that although the number of CD4+GITR+ T cells was similar between draining and nondraining lymph node, their function might be different.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Ag-experienced CD4+GITR+ T cells express more FoxP3 and secrete higher levels of IL-10 than naive CD4+GITR+ T cells upon antigenic stimulation. C57BL/6J mice were immunized with bovine PV L1 virus like particles on days 0 and 14, and draining and nondraining lymph nodes harvested on day 20. A, Expression of Foxp3 and GITR on CD4 cells from draining and nondraining nodes. B, Expression of FoxP3 on CD4+ GITR+ cells by triple staining flow cytometry (left) on draining and nondraining nodes (right). C, FACS sorted CD4+GITR+ T cells from draining and nondraining nodes, and from unimmunized animals, were assessed for IL-10 production after culture with or without membrane bound anti-CD3 Ab. D, CD11c+ DCs (0.5 × 105), previously exposed to 40 μg/ml bovine PV L1 virus-like particles overnight or left unexposed, were cocultured overnight with 0.5 × 105 of FACS sorted CD4+GITR+ or CD4+GITR− T cells from draining and nondraining lymph nodes of bovine PV L1 virus like particle immunized mice. IL-10 level from supernatants were measured by ELISA. Results throughout are the mean and 1 SEM of triplicates and represent one of two independent experiments. NT in C and D means not tested.

To study the capacity of Ag-experienced and naive CD4+GITR+ T cells to secrete IL-10 in response to stimulation, CD4+GITR+ cells from unimmunized mice, and from draining and nondraining lymph nodes from VLP immunized mice, were cultured in vitro with or without anti-CD3 Ab, and IL-10 produced in culture supernatants was measured by ELISA. After stimulation by anti-CD3, CD4+GITR+ T cells from draining lymph nodes secreted higher levels of IL-10 (Fig. 1⇑C) than CD4+GITR+ T cells from naive or nondraining lymph nodes. To investigate whether Ag-specific stimulation generated similar results, CD11c+ cells were pulsed with L1VLPs and then cocultured with GITR+CD4+ T cells from draining or nondraining lymph nodes, or GITR-CD4+ T cells from draining lymph nodes. CD4+GITR+ T cells responded to cognate Ag stimulation similarly to anti-CD3 stimulation: GITR+ cells from draining lymph nodes produced high level of IL-10, unlike GITR+ cells from nondraining lymph nodes, and GITR− cells from draining lymph nodes (Fig. 1⇑D). These data demonstrate that CD4+GITR+ T cells induced by immunization and responsive to cognate Ag are the main producers of IL-10 upon repriming, indicating these cells might be the cells that mediate in vivo suppression of induction of IFN-γ secreting CD8 T cells following reimmunisation.

Ag-experienced CD4+GITR+ T cells secrete high levels of IFN-γ, and IFN-γ signaling is required for inhibition of induction of IFN-γ secreting CD8 T cells

Recently, IFN-γ and IL-10 secreting CD4 T cells have been show to have regulatory function in parasitic infection (24, 25). We therefore investigated whether IFN-γ signaling was required for inhibition of induction of IFN-γ secreting CD8 T cells in an Ag primed animal. We first determined whether Ag experienced CD4+GITR+ T cells produce IFN-γ upon TCR stimulation. Ag-experienced and naive CD4+GITR+ T cells were stimulated with anti-CD3 Ab, and supernatants were assessed for IFN-γ, TNF-α, IL-6, and MCP-1. Neither naive nor Ag-experienced CD4+GITR+ T cells produced IL-6, while only Ag-experienced CD4+GITR+ T cells produced IFN-γ and TNF-α. (Fig. 2⇓A). Intracellular staining results show that there is a fraction of CD4+GITR+ T cells secreting both IL-10 and IFN-γ (Fig. 2⇓A, FACS data). To investigate whether IFN-γ contributes to inhibition of induction of IFN-γ secreting CD8 T cells in response to further Ag exposure in an Ag experienced animal, we tested whether such inhibition could be observed in IFN-γR−/− mice. Naive IFN-γR−/− mice generate slightly higher E7 specific IFN-γ CD8 T cell numbers in response to immunization than naive wild-type C57BL/6 mice (Fig. 2⇓B) after L1E7VLPs immunization. After priming with L1VLPs, and subsequent immunization with L1E7 VLPs, IFN-γR−/− mice mounted significantly greater E7 specific IFN-γ secreting CD8 T cell responses than IFN-γR+/+ mice similarly immunized, and these were similar in number to the CD8 response to L1E7 VLPs in naive animals (Fig. 2⇓B). Thus, IFN-γ signaling is inhibitory to the optimal induction of specific CD8 responses in Ag-primed mice and both IL-10 and IFN-γ signaling contribute to inhibition.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Ag-experienced CD4+GITR+ T cells secrete IFN-γ which can inhibit generation of specific CTL. A, left, CD4+GITR+ T cells from draining and nondraining lymph nodes of naive or bovine BPVL1 VLPs immunized mice on days 0 and 14 were FACS sorted and cultured at 0.5 × 105 per well with or without membrane bound anti-CD3 Ab overnight, and supernatants assessed for cytokine secretion by multi cytokine array methods described in Materials and Methods. A, right, FACS results: C57BL/6 mice were immunized with virus like particles on days 0 and 14. Two days after final immunization, single cells from draining lymph nodes were directly stimulated with PMA and ionomycin for 5 h, stained for CD4 GITR, and then intracellularly stained for IL-10 and IFN-γ. CD4+GITR+ T cells were gated and intracellular IFN-γ and IL-10 shown. B, C57BL/6 and C57BL/6 IFN-γR−/− mice were immunized with bovine BPVL1 virus like particles on days 0 and 14, or left unimmunized. On days 21 and 35, all mice were immunized with chimeric L1E7VLPs. Six days after final immunization, the number of E7 specific IFN-γ secreting CD8 cells per 106 splenocytes was assessed by ELISPOT for all mice. Results are shown for each mouse individually and pooled from two independent experiments.

CD11c+ cells from IFN-γ receptor knockout but not wild-type mice secrete more IL-10 and less IL-12 upon stimulation with VLPs

We next wished to establish a mechanism by which IFN-γ might inhibit induction of CD8 T cells. Professional Ag presentation cells play a critical role in controlling the adaptive immune response, and can respond to IFN-γ. However, IFN-γ negatively regulates IL-10 secretion by macrophages and dendritic cells (DCs) (26, 27). To establish whether IFN-γ-mediated inhibition of induction of CD8 T cells might be mediated by a phenotypic change in DC, CD11c+ cells isolated from mouse spleen were exposed either to L1VLPs or to Zymosan, a TLR3 agonist, as a positive control, in the presence or absence of IFN-γ. CD11c+ cells from IFN-γ R−/− mice, whether stimulated with VLPs or Zymosan, produced less IL-12 and more IL-10 than those from C57BL/6 mice (Fig. 3⇓A). To examine the contribution of IFN-γ to the response, CD11c+ cells were then stimulated with VLPs with or without IFN-γ. IL12p40 levels were higher if DCs were stimulated with VLP in the presence of IFN-γ (Fig. 3⇓B). DCs stimulated with Zymosan with or without IFN-γ showed similar results (data not shown). These results suggested that IFN-γ signaling through DCs would promote Th1 responses, and was therefore unlikely to be responsible for the observed IFN-γ mediated inhibition of induction of IFN-γ-secreting CD8 T cells.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

CD11c+ cells from IFN-γR−/− mice secrete more IL-10 and less IL-12 upon antigenic stimulation. A, CD11c+ DCs (105) from C57BL/6 or IFN-γR−/− mice were left exposed to 40 μg/ml bovine PV virus-like particles (VLP) or 50 μg/ml Zymosan for 18 h and supernatants were assayed for IL-10 and IL-12 by ELISA. Results are the means and 1 SEM of triplicates and represent one of two independent experiments. B, CD11c+ DCs (105) from C57BL/6 mice were exposed to L1VLPs (40 μg/ml) and IFN-γ at differing concentrations as shown, or were left unexposed to VLPs (unpulsed). Culture supernatants were assayed for IL-12 by ELISA. Results are the means and 1 SEM of triplicates.

E7-specific IFN-γ inhibition can be observed in CD1d knockout mice

NKT cells are the main producer of IFN-γ at the early stage of an immune response. We therefore wished to establish whether IFN-γ secreted from NKT cells might contribute to the inhibition of induction of IFN-γ-secreting CD8 T cells observed in Ag-primed mice. We primed CD1d knockout mice, which lack CD1d restricted NKT cells, with L1VLPs and then further immunized these animals with L1E7VLPs. We measured E7 peptide-specific IFN-γ secretion by CD8 T cells. Naive CD1d−/− mice developed E7-specific IFN-γ-secreting CD8 cells in response to immunization, and showed impaired responses when previously primed with L1VLPs in the same manner that CD1d replete animals did (Fig. 4⇓), demonstrating that CD1d restricted NKT cells and therefore IFN γ secretion by NKT cells are not necessary for inhibition of induction of CD8 T cells following priming.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

CD1d+ T cells are not required for inhibition of CD8 T cell responses following Ag exposure. Groups of C57BL/6 mice and C57 BL/6 CD1d−/− mice were either left unimmunized or immunized with bovine PV virus-like particles on days 0 and 14. On days 21 and 35, mice were immunized with chimeric L1E7 bovine PV virus-like particles. Six days after the final immunization, the frequency of E7 specific IFN-γ secreting T cells in spleen was measured by ELISPOT assay. Results shown were from one of two independent experiments.

Viral capsid protein-experienced CD4+GITR+ T cells have higher IFN-γ receptor expression and optimal IL-10 secretion by these cells requires IFN-γ signaling

Inhibition of induction of IFN-γ-secreting CD8 T cells following priming requires Ag experienced CD4 T cells, IL-10, and IFN-γ signaling. We hypothesized that IFN-γ signaling to CD4+GITR+ T cells might be required for their acquisition of a suppressor phenotype, and that Ag experienced FoxP3+CD4+GITR+ T cells might express more IFN-γR than their naive FoxP3- counterparts. We first investigated the IFN-γ receptor α- and β-chain expression on CD4+GITR+ cells. The percentage of cells expressing IFN-γ α- and β-chain (Fig. 5⇓A) was higher in CD4+GITR+ cells in both draining and nondraining lymph nodes compared with CD4+GITR− cells. The results were consistent from three independent experiments. The mean fluorescence intensity of IFN-γ α- or β-chain on CD4+GITR+ T cells was higher than on CD4+GITR− T cells, whether from draining or nondraining lymph nodes (Fig. 5⇓A, right). Next, we identified Foxp3, IFN-γR β-chain and CD4 expression on cells from draining or nondraining lymph nodes of immunized mice. The percentage of CD4+Foxp3+ cells expressing IFNgR β-chain was similar in draining and nondraining lymph nodes (Fig. 5⇓B). We therefore investigated whether IFN-γ signaling to Ag experienced CD4+GITR+ T cells promoted IL-10 secretion by these cells. CD4+GITR+ T cells from C57BL/6 or IFN-γR−/− mice were stimulated with anti-CD3 Ab; supernatants were measured for IL-10 level. As shown in Fig. 5⇓C, IL-10 secretion by CD4+GITR+ T cells from C57BL/6 mice was twice that seen from the same cell population from IFN-γR−/− mice. Intracellular staining of cells for IL-10 confirmed these findings (Fig. 5⇓C, FACS results), and neutralizing IFN-γ reduced IL-10 secretion from GITR+ cells (Fig. 5⇓C). We confirmed these findings using Ag-experienced CD4+GITR+ T cells from OVA/LPS immunized C57BL/6 mice, and these also produced more IL-10 than cells from similarly immunized IFN-γR−/− mice (214 ± 7pg/ml vs 137 ± 1pg/ml). Taken together, these results revealed that IFN-γ signaling through Ag-experienced GITR+CD4+ T cells, unlike IFN-γ signaling through DCs, regulates secretion of IL-10, the key cytokine for induction of the suppressor phenotype.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Ag-experienced CD4+GITR+ T cells have higher IFN-γ receptor expression and optimal IL-10 secretion by these cells requires IFN-γ signaling. C57BL/6J mice were immunized with bovine PV virus-like particles on days 0 and 14 or left unimmunised. Draining and nondraining lymph nodes cells were assessed (A) for CD4, GITR, and IFN-γ receptor α- and β-chain expression on day 20. Left, FACS profiles; Right, Mean fluorescence intensity for IFN-γ receptor α- or β-chain and (B) for CD4, Foxp3, and for IFN-γR β-chain on day 17. C, left, FACS-sorted Ag experienced CD4+GITR+ T cells were stimulated with anti-CD3 in the presence or absence of anti-IFN-γ Ab overnight, and supernatants were assayed for IL-10. Results are representing of two independent experiments. Right: Group of three C57BL/6 or IFN-γR−/− mice were immunized with BPVL1 twice as indicated in the Materials and Methods, Ag-experienced CD4+GITR+ T cells were isolated by MACs beads and stimulated with membrane bound anti-CD3 for 18 h, IL-10 level from supernatants were measured by ELISA. Right, FACS profile, C57BL/6 or IFN-γR−/− mice were immunized with VLPs twice as indicated in the Materials and Methods, Ag-experienced CD4+GITR+ T cells were isolated by MACs beads and stimulated with 1 μg/ml anti-CD3 and equal number of CD11c+ cells for 48 h, then stimulated with PMA and ionomycin for 5 h before performing intracellular staining for IL-10 and IFN-γ as described in Materials and Methods.

OVA/LPS immunization generate IL-10 secreting CD4+ T cells and neutralizing IL-10 overcome CTL inhibition in OVA/LPS-primed host

To investigate whether the CTL inhibition observed in VLP-primed mice could be demonstrated for a soluble protein Ag as well as a particulate viral Ag, mice were primed with OVA/LPS, and then immunized with OVA/LPS alone, or coadministered with anti-IL-10R Ab or normal rat serum. OVA CD8-specific IFN-γ responses were determined by ELISPOT assay. OVA-specific CD8 T effector cells were more frequent in OVA experience mice reimmunized with OVA/LPS, and also administered anti-IL-10R Ab, when compared with animals similarly immunized but not administered anti-IL-10R (Fig. 6⇓). As observed with BPV VLP Ag, OVA/LPS primed CD4+ T cells, especially CD4+GITR+ T cells, produced high amount of IL-10. Thus, whether examined for OVA or for bovine papillomavirus L1 protein, prior immunity to Ag inhibits generation of new CTL responses following further immunization, and neutralizing IL-10 at the time of Ag administration in an already Ag primed animal can overcome this inhibition.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Neutralizing IL-10 increases OVA specific CTL responses to immunization in OVA/LPS primed animals. A, Group of four C57BL/6J mice were primed with 100 μg of OVA with 30 μg of LPS on day 0, and then boosted with same amount of OVA/LPS on day 14 in the presence of 0.5 mg/ml anti-IL-10R Ab or rat serum i.p.; 6 days after final immunization, spleen from immunized mice were collected and ELISPOT assay performed. Results were pooled from two independent experiments. B, Two C57BL/6 mice were immunized i.p. with OVA/LPS as indicated in Materials and Methods; Ag-experienced CD4, CD4+GITR+, and CD4+GITR− T cells were isolated by MACs beads and stimulated with anti-CD3 and equal number of spleen CD11c+ cells for 48 h before IL-10 level of the supernatants were measured by ELISA. Results throughout are the mean and 1 SEM of triplicates and represent one of two independent experiments.

Discussion

We and others (28) observed previously that CTL responses to Ags and epitopes linked to papillomavirus capsid protein are inhibited in papillomavirus capsid protein-experienced mice. We also found that neutralizing IL-10 during immunization can restore the inhibited CTL response in an Ag-experienced host (9, 10). These results suggested that IL-10 inhibition might improve the efficacy of immunotherapeutic immunization as an intervention for chronic viral infection and cancer, where Ag exposure before immunization is to be expected and were to date immunotherapy has proven only minimally effective despite clear identification of target Ags and use of vaccines able to induce cytotoxic T cell responses in naive animals. Recently, neutralizing IL-10 with immunization has been shown to assist more effectively than immunization or neutralizing IL-10 alone with clearance of a chronic viral infection, lymphocytic choriomeningitis virus (11, 13, 29).

In the current study, we demonstrate that inhibition of CTL responses in an Ag-experienced host can be observed with two different categories of Ag, a soluble and nonstimulatory Ag, OVA, when coadministered with a TLR4 agonist, LPS, and a particulate Ag known to stimulate TLR 4 directly (30), papillomavirus capsid. In each case, in a primed animal, a population of Ag-experienced CD4+GITR+ T cells secrete IL-10 and IFN-γ in responses to further Ag stimulation, and optimal IL-10 secretion by Ag-experienced CD4+GITR+ T cells requires IFN-γ receptor signaling to the CD4 cell population. Although it is likely that IFN-γ signaling via CD4 cells is responsible for IL-10 mediated suppression of CD8 responses in the Ag primed host, we nevertheless tested other mechanisms by which IFN-γ might contribute. IFN-γ signaling through VLP pulsed DCs promoted IL12 secretion, and DCs lacking the IFN-γ receptor produce less IL-12 and increased amount of IL-10 upon stimulation with papillomavirus VLPs, or the TLR agonist zymosan. These data indicate that IFN-γ signaling enhances induction by DCs of a Th1 type T cell response (27). Thus, IFN-γ signaling via DC is unlikely to promote the inhibition of E7-specific CD8 responses in an Ag-experienced host. We also demonstrated that CD1d restricted NKT cells are not required for the inhibition of E7 specific CD8 T cells responses. Thus, IFN-γ, a key effector molecule secreted by CD8 T cells, plays a paradoxical regulatory role to restrain the CD8 immune responses in an Ag-experienced animal, most likely through positive regulation of IL-10 production by Ag experienced CD4+GITR+ T cells. We confirm in this study using three different methods (neutralization of IFN-γ by Ab, IL-10 ELISA after stimulation of CD4+GITR+ T cells from wild-type and IFN-γR−/− mice, and intracellular staining of these cells after culture with DCs in the presence of anti-CD3) that a bulk culture of CD4+GITR+ T cells from the draining lymph node of an immunized animal, presumably enriched for but not entirely comprising cells of this phenotype induced in response to immunization, produce twice as much as IL-10 after stimulation and with the ability to respond to IFN-γ as cells similarly manipulated but not able to respond to IFN-γ. After stimulation, we could not detect IL-10 by intracellular staining, preventing determination of whether a small number of CD4+GITR+ cells produce large amounts of IL-10 in the presence of IFN-γ, or the majority of such cells produce low levels when IFN γ stimulation is available. CD4+GITR+ cells from draining lymph nodes of immunized animals may contain different populations of CD4+ T cells. However, while naturally occurring CD4+CD25+Foxp3+ T cells are within this population, our data show that they are not responsible for the observed inhibition in our model system (10). However, any local increase in concentration of IL-10 induced by IFN-γ signaling is likely to impact on the CD8 T cell response to presented Ag, and the 2-fold increase in IL-10 seen in in vitro bulk culture is a minimum estimate of the local change in concentration that would be observed in the vicinity of an Ag-presenting cell in the lymph node. The mechanisms by which IL-10 and IFN-γ modulate CTL responses in an Ag-experienced host in vivo may in any case be more complicated, as many cell types can respond to IL-10 and IFN-γ signaling pathways (31, 32). We are currently investigating which fraction of CD4+GITR+ T cells are inhibitory in an Ag-experienced host. It has been suggested that lack of IFN-γ signaling promotes Th17 CD4 T cells (33), but we did not find increased IL-17 production by draining lymph node CD4+ T cells (data not shown). Recently, it has been demonstrated that IFN-γ signaling promotes Foxp3 expression by CD4+CD25− T cells (34) and induces apoptosis of Ag-experienced CD4+ T cells in a tumor model (35). Our results demonstrate a further and previously unappreciated role for IFN-γ signaling through Ag-experienced CD4+GITR+ T cells as a control of generation of cytotoxic T cell immune responses.

Our data showed that CD4+GITR+ T cells differentially express IFN-γ receptor when compared with CD4+GITR− T cells, suggesting they are better able to respond to IFN-γ signaling. In a Toxoplasma gondii infection model, IL-10 from CD4 T cells mediated suppression of Th1 responses and was enhanced by IFN-γ signaling (36). In OVA/LPS and also VLP-primed mice, we observed that a small fraction of CD4+GITR+ T cells (around 3%) secrete both IL-10 and IFN-γ (Fig. 2⇑A). It has been demonstrated in different parasite models that T bet+ Th1 cells are the source of IL-10 and are responsible for the immune suppression (24, 25), these cells may be responsible for the CTL inhibition observed in our system. Interestingly, IFNαR−/−, or IFNβ−/− mice have normal CD25+Foxp3+ T cells compared with wild-type mice but generate 2- or 3-fold lower numbers of IL-10 producing CD4+ T cells after immunization (37). Thus, each member of the family of IFNs appears to enhance generation of IL-10 secreting CD4+GITR+ regulatory T cells.

It is currently uncertain how a small population of Ag experienced CD4+GITR+ T cells, through secretion of IL-10, influences so profoundly the CD8 T cell response to a novel MHC class 1 restricted epitope encountered in association with a previously encountered Ag. CCR7 is required for the in vivo function of CD4+CD25+ T cells (38), and CCR5 expression on CD4 T cells is required for optimal attraction of CD8 T cells to DCs within the lymph nodes (38). It will be interesting to check whether Ag-experienced CD4+GITR+ T cells are more easily attracted to DCs to present cognate Ags in an Ag-experienced host, through differential display of chemokine receptors.

Our results demonstrate how a population of Ag-experienced IL-10 and IFN-γ secreting CD4+GITR+ T cells inhibit induction of new CD8 T cell responses to the cognate Ag in the Ag-experienced host, and show that this process is enhanced by IFN-γ signaling. Neutralizing IFN-γ as well as IL-10 at the time of immunization may therefore assist in generation of effector CTL function in an Ag-experienced host.

Acknowledgments

We thank Ibtissam Abdul Jabbar for cell sorting; Alison Choyce for technical assistance; Caron Maxim, Rebecca Coulter, and Megan Bathurst for the excellent animal care; and Prof. Ranjeny Thomas, Dr. Raymond Steptoe, and Dr. Jiezhong Chen for helpful discussion.

Disclosures

The authors have no financial conflict of interest.

Footnotes

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • ↵1 This research was supported by National Health and Medical Research Council program Grant No. 351439, and Grants from the Cancer Council Queensland Q42, the Australian Cancer Research Foundation, and the Cancer Research Institute, New York. X.S.L. was supported by a University of Queensland early career award, G.R.L. by a Lions Research Foundation fellowship, and I.H.F. by a Queensland Government Premier’s fellowship.

  • ↵2 Address correspondence and reprint requests to Prof. Ian Frazer, Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia. E-mail address: i.frazer{at}uq.edu.au

  • ↵3 Abbreviations used in this paper: HPV, human papillomavirus; Sf-9, Spodoptera frugiperda; VLP, virus like particle; DC, dendritic cell; GITR, glucocorticoid-induced tumor necrosis factor receptor.

  • Received June 24, 2008.
  • Accepted April 22, 2009.
  • Copyright © 2009 by The American Association of Immunologists, Inc.

References

  1. ↵
    Rosenberg, S. A., J. C. Yang, N. P. Restifo. 2004. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915.
    OpenUrlCrossRefPubMed
  2. ↵
    Nonnenmacher, B., N. L. Hubbert, R. Kirnbauer, K. V. Shah, N. Munoz, F. X. Bosch, S. de Sanjose, R. Viscidi, D. R. Lowy, J. T. Schiller. 1995. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J. Infect. Dis. 172: 19-24.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Carter, J. J., G. C. Wipf, M. E. Hagensee, B. McKnight, L. A. Habel, S. K. Lee, J. Kuypers, N. Kiviat, J. R. Daling, L. A. Koutsky, et al 1995. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J. Infect. Dis. 172: 11-18.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Villa, L. L., R. L. Costa, C. A. Petta, R. P. Andrade, K. A. Ault, A. R. Giuliano, C. M. Wheeler, L. A. Koutsky, C. Malm, M. Lehtinen, et al 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6: 271-278.
    OpenUrlCrossRefPubMed
  5. ↵
    Greenstone, H. L., J. D. Nieland, K. E. de Visser, M. L. De Bruijn, R. Kirnbauer, R. B. Roden, D. R. Lowy, W. M. Kast, J. T. Schiller. 1998. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc. Natl. Acad. Sci. USA 95: 1800-1805.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Peng, S., I. H. Frazer, G. J. Fernando, J. Zhou. 1998. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology 240: 147-157.
    OpenUrlCrossRefPubMed
  7. ↵
    Liu, W. J., X. S. Liu, K. N. Zhao, G. R. Leggatt, I. H. Frazer. 2000. Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes. Virology 273: 374-382.
    OpenUrlCrossRefPubMed
  8. ↵
    Kaufmann, A. M., J. D. Nieland, I. Jochmus, S. Baur, K. Friese, J. Gabelsberger, F. Gieseking, L. Gissmann, B. Glasschroder, T. Grubert, et al 2007. Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3). Int. J. Cancer 121: 2794-2800.
    OpenUrlCrossRefPubMed
  9. ↵
    Liu, X. S., Y. Xu, L. Hardy, V. Khammanivong, W. Zhao, G. J. Fernando, G. R. Leggatt, I. H. Frazer. 2003. IL-10 mediates suppression of the CD8 T cell IFN-γ response to a novel viral epitope in a primed host. J. Immunol. 171: 4765-4772.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Liu, X. S., J. Dyer, G. R. Leggatt, G. J. Fernando, J. Zhong, R. Thomas, I. H. Frazer. 2006. Overcoming original antigenic sin to generate new CD8 T cell IFN-γ responses in an antigen-experienced host. J. Immunol. 177: 2873-2879.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309.
    OpenUrlCrossRefPubMed
  12. ↵
    Brooks, D. G., A. M. Lee, H. Elsaesser, D. B. McGavern, M. B. Oldstone. 2008. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J. Exp. Med. 205: 533-541.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Ejrnaes, M., M. G. von Herrath. 2007. Cure of chronic viral infection by neutralizing antibody treatment. Autoimmun. Rev. 6: 267-271.
    OpenUrlCrossRefPubMed
  14. ↵
    Sakaguchi, S.. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
    OpenUrlCrossRefPubMed
  15. ↵
    Roncarolo, M. G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, M. K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50.
    OpenUrlCrossRefPubMed
  16. ↵
    Couper, K. N., D. G. Blount, E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Wang, H. Y., D. A. Lee, G. Peng, Z. Guo, Y. Li, Y. Kiniwa, E. M. Shevach, R. F. Wang. 2004. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20: 107-118.
    OpenUrlCrossRefPubMed
  18. ↵
    van der Burg, S. H., S. J. Piersma, A. de Jong, J. M. van der Hulst, K. M. Kwappenberg, M. van den Hende, M. J. Welters, J. J. Van Rood, G. J. Fleuren, C. J. Melief, et al 2007. Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. Proc. Natl. Acad. Sci. USA 104: 12087-12092.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Zhou, G., C. G. Drake, H. I. Levitsky. 2006. Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 107: 628-636.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Feltkamp, M. C., H. L. Smits, M. P. Vierboom, R. P. Minnaar, B. M. de Jongh, J. W. Drijfhout, J. ter Schegget, C. J. Melief, W. M. Kast. 1993. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16- transformed cells. Eur. J. Immunol. 23: 2242-2249.
    OpenUrlCrossRefPubMed
  21. ↵
    Peng, S., I. H. Frazer, G. J. Fernando, J. Zhou. 1998. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology 240: 147-157.
    OpenUrlCrossRefPubMed
  22. ↵
    Liu, X. S., I. Abdul-Jabbar, Y. M. Qi, I. H. Frazer, J. Zhou. 1998. Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice. Virology 252: 39-45.
    OpenUrlCrossRefPubMed
  23. ↵
    Khammanivong, V., X. S. Liu, W. J. Liu, S. J. Rodda, G. R. Leggatt, R. W. Tindle, I. H. Frazer, G. J. Fernando. 2003. Paucity of functional CTL epitopes in the E7 oncoprotein of cervical cancer associated human papillomavirus type 16. Immunol. Cell. Biol. 81: 1-7.
    OpenUrlCrossRefPubMed
  24. ↵
    Jankovic, D., M. C. Kullberg, C. G. Feng, R. S. Goldszmid, C. M. Collazo, M. Wilson, T. A. Wynn, M. Kamanaka, R. A. Flavell, A. Sher. 2007. Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204: 273-283.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Anderson, C. F., M. Oukka, V. J. Kuchroo, D. Sacks. 2007. CD4+CD25−Foxp3− Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204: 285-297.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Hu, X., P. K. Paik, J. Chen, A. Yarilina, L. Kockeritz, T. T. Lu, J. R. Woodgett, L. B. Ivashkiv. 2006. IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24: 563-574.
    OpenUrlCrossRefPubMed
  27. ↵
    Flores, R. R., K. A. Diggs, L. M. Tait, P. A. Morel. 2007. IFN-γ negatively regulates CpG-induced IL-10 in bone marrow-derived dendritic cells. J. Immunol. 178: 211-218.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Da Silva, D. M., D. V. Pastrana, J. T. Schiller, W. M. Kast. 2001. Effect of preexisting neutralizing antibodies on the anti-tumor immune response induced by chimeric human papillomavirus virus-like particle vaccines. Virology 290: 350-360.
    OpenUrlCrossRefPubMed
  29. ↵
    Brooks, D. G., A. M. Lee, H. Elsaesser, D. B. McGavern, M. B. Oldstone. 2008. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J. Exp. Med. 205: 533-541.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Yan, M., J. Peng, I. A. Jabbar, X. Liu, L. Filgueira, I. H. Frazer, R. Thomas. 2005. Activation of dendritic cells by human papillomavirus-like particles through TLR4 and NF-κB-mediated signalling, moderated by TGF-β. Immunol. Cell. Biol. 83: 83-91.
    OpenUrlCrossRefPubMed
  31. ↵
    Moore, K. W., R. de Waal Malefyt, R. L. Coffman, A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
    OpenUrlCrossRefPubMed
  32. ↵
    Schroder, K., P. J. Hertzog, T. Ravasi, D. A. Hume. 2004. Interferon-γ: an overview of signals, mechanisms and functions. J. Leukocyte Biol. 75: 163-189.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    McGeachy, M. J., D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453.
    OpenUrlCrossRefPubMed
  34. ↵
    Wang, Z., J. Hong, W. Sun, G. Xu, N. Li, X. Chen, A. Liu, L. Xu, B. Sun, J. Z. Zhang. 2006. Role of IFN-γ in induction of Foxp3 and conversion of CD4+ CD25− T cells to CD4+ Tregs. J. Clin. Invest. 116: 2434-2441.
    OpenUrlCrossRefPubMed
  35. ↵
    Berner, V., H. Liu, Q. Zhou, K. L. Alderson, K. Sun, J. M. Weiss, T. C. Back, D. L. Longo, B. R. Blazar, R. H. Wiltrout, et al 2007. IFN-γ mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy. Nat. Med. 13: 354-360.
    OpenUrlCrossRefPubMed
  36. ↵
    Shaw, M. H., G. J. Freeman, M. F. Scott, B. A. Fox, D. J. Bzik, Y. Belkaid, G. S. Yap. 2006. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-γ-dependent IL-10 reactivation. J. Immunol. 176: 7263-7271.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Dikopoulos, N., A. Bertoletti, A. Kroger, H. Hauser, R. Schirmbeck, J. Reimann. 2005. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J. Immunol. 174: 99-109.
    OpenUrlAbstract/FREE Full Text
  38. ↵
    Schneider, M. A., J. G. Meingassner, M. Lipp, H. D. Moore, A. Rot. 2007. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J. Exp. Med. 204: 735-745.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 183 (1)
The Journal of Immunology
Vol. 183, Issue 1
1 Jul 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
IFN-γ Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
IFN-γ Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host
Xiao Song Liu, Joanne Leerberg, Kelli MacDonald, Graham R. Leggatt, Ian H. Frazer
The Journal of Immunology July 1, 2009, 183 (1) 51-58; DOI: 10.4049/jimmunol.0802047

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
IFN-γ Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host
Xiao Song Liu, Joanne Leerberg, Kelli MacDonald, Graham R. Leggatt, Ian H. Frazer
The Journal of Immunology July 1, 2009, 183 (1) 51-58; DOI: 10.4049/jimmunol.0802047
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Disclosures
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606